USPTO 2015–2025 USPTO PatentsView US Corporation

Vedanta Biosciences, Inc.

USPTO PatentsView assignee record - 15 granted patents across 8 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Vedanta ranks #19,321 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 8 technology areas.

#19,321
of 49,997 US assignees by volume
Top 49%
by Innovation Score (35.5/100)
15.5
avg claims per patent
+0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19321 · US Corporation #19,321 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-MICRO 15 grants
  • MID-PACK #19,321/49,997
  • PHOTO-FINISH Valo Early Discovery
  • CPC-NARROW A61K · 8 areas
  • INNOV-THIN 35.5/100
  • CLAIMS-RICH 15.5 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-FLAT +0% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Valo Early Discovery, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Vedanta’s 35.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Vedanta

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Vedanta's Innovation Score is 35.5/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Vedanta?

Each dot is one of Vedanta’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Vedanta’s own 15.5 claims/patent is at or below the 17.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Vedanta vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 14.914.91515.1 051015202530 Granted patents (volume) Avg claims / patent Valo Early Discovery, Inc. - 15, 18Valo Early Discov…Valve Medical Ltd. - 15, 23.73Valve MedicalVascular Imaging Corporation - 15, 15.07Vascular ImagingVaxxas Pty Limited - 15, 16.53Vaxxas PtyVentureMed Group, Inc. - 15, 17.47Venturemed GroupVeritone Alpha, Inc. - 15, 25.53Veritone AlphaVerona Pharma PLC - 15, 17.27Verona PharmaVi-Jon, LLC - 15, 5.93Vi-jonVedanta Biosciences, Inc. - 15, 15.47Vedanta Bioscienc…
Vedanta vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Vedanta's grants concentrate

Vedanta Biosciences, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 86.7% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2018 (3 grants) versus a trough of 1 in 2017. By volume, Vedanta sits between Valo Early Discovery, Inc. and Vi-Jon, LLC.

Vedanta's three-year grant acceleration

Vedanta Biosciences, Inc. shows 5 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Vedanta's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Vedanta holds 15 patents at rank #19,322, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Vedanta

By rank, the assignees closest to #19,322 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Vedanta's primary technology class.

Vedanta's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 49% higher than 51% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 201720182019202020212022202320242025 1
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Vedanta Biosciences, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 1 6.7%
2018 3 20.0%
2019 3 20.0%
2020 1 6.7%
2021 1 6.7%
2022 1 6.7%
2023 2 13.3%
2024 2 13.3%
2025partial year 1 6.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Vedanta Biosciences, Inc.'s patent record in context - here's where to go next.

  • Vedanta Biosciences, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 86.7% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #19,321 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Vedanta Biosciences, Inc. against Valo Early Discovery, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 35.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.